Same question as Peeteman, What are your thoughts on the various connections? Dr Higgins being on Ned Medicals Board, Zimmer Biomet's Arthur Higgins being an advisor to ADIA, ADIA being a major investor in TVM Capital, & Sintx board member Robert Mitchell being an advisor to TVM? Not to mention Mr Lyons who just got done selling a company to Zimmer Biomet last year. The moment i saw that an advisor to TVM had joined Sintx board i speculated their future investment in Sintx. So i find the above interesting.
Do they continue to pass or have they just been waiting? Zimmer & Biomet have been behind the curtain for 20 years for some reason. Why they will not make their partnership with Sintx public knowledge is something i have never understood but it could be tied, in part, to what i say next.
Your premise that because something hasnt happened it will never is flawed. For one thing pre-IPO investors obviously needed to return before something could happen. Now that a few have, management is buying shares after a decade of not really doing so. Sintx is even repurchasing shares. Lastly, they have said they intend to unlock the full value of Sintx IP. To do that they must take those various strategic partnerships to the next level.
accelerate commercialization and unlock the full value of its intellectual property portfolio
https://investorshub.advfn.com/Bostons-research-43724 Could it be that there is a strategy to distract people away from looking at basic data? Is it an exercise to create forum verbiage to drown out any serious discussion of evidence?